HOMA-IR (Using C-Peptide)

Diabetes

Report in 4Hrs

At Home

Fasting Required

Details

Estimates insulin resistance.

₹962₹1,374

30% OFF

HOMA-IR (Using C-Peptide) - Comprehensive Medical Test Guide

Why is it done?
- Test Purpose: HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) using C-peptide is a mathematical calculation used to assess insulin resistance and beta cell function. It measures the degree to which the body's cells are resistant to the effects of insulin, indicating metabolic dysfunction.
- Primary Indications: Screening for insulin resistance in at-risk populations
- Evaluation of prediabetes and type 2 diabetes risk
- Assessment of polycystic ovary syndrome (PCOS)
- Diagnosis of metabolic syndrome
- Evaluation of patients with obesity and metabolic dysfunction
- Assessment of cardiovascular risk in insulin-resistant patients
- Typical Timing/Circumstances: During routine preventive health screening, annual physicals for high-risk individuals, metabolic workup for suspected diabetes or prediabetes, fertility evaluation in women with PCOS, and cardiovascular risk assessment in patients with metabolic syndrome components.
Normal Range
- Reference Range Values: HOMA-IR < 2.0 is generally considered normal and indicates good insulin sensitivity
- HOMA-IR 2.0-2.5 is considered borderline and may indicate mild insulin resistance
- HOMA-IR > 2.5-3.0 generally indicates moderate to significant insulin resistance
- HOMA-IR > 5.0 indicates severe insulin resistance
- Units of Measurement: HOMA-IR is expressed as a unitless index or ratio calculated from fasting glucose (mg/dL or mmol/L) and fasting C-peptide (ng/mL or pmol/L)
- Result Interpretation: Lower values indicate better insulin sensitivity and normal metabolic function. Higher values indicate increasing degrees of insulin resistance and metabolic dysfunction. HOMA-IR is not classified as positive or negative but rather as a spectrum of insulin resistance severity.
- Normal vs Abnormal: Normal HOMA-IR values indicate good insulin sensitivity and lower metabolic disease risk. Abnormal (elevated) values suggest the pancreas must work harder to control blood glucose, increasing risk for type 2 diabetes and cardiovascular disease.
Interpretation
- HOMA-IR < 1.0: Excellent insulin sensitivity; optimal metabolic health with minimal risk for metabolic disease
- HOMA-IR 1.0-2.0: Normal insulin sensitivity; cells respond well to insulin; acceptable metabolic function
- HOMA-IR 2.0-2.5: Borderline/mild insulin resistance; early warning sign; should implement lifestyle modifications; monitor for progression to prediabetes
- HOMA-IR 2.5-3.0: Moderate insulin resistance; significant metabolic dysfunction; increased risk for type 2 diabetes, cardiovascular disease, and metabolic syndrome; requires intervention
- HOMA-IR 3.0-5.0: High insulin resistance; substantially elevated metabolic disease risk; probable prediabetes or metabolic syndrome; aggressive intervention needed
- HOMA-IR > 5.0: Severe insulin resistance; high likelihood of type 2 diabetes, metabolic syndrome, and cardiovascular disease; immediate comprehensive intervention and close monitoring required
- Factors Affecting Results: Obesity and increased body weight; sedentary lifestyle and lack of physical activity; poor dietary habits; hormonal status and menstrual cycle phase in women; medications (corticosteroids, antipsychotics, statins); stress levels; sleep deprivation; smoking; alcohol consumption; recent illness or infection; time of blood draw; season; age-related changes; ethnicity and genetic predisposition; liver disease; kidney dysfunction
- Clinical Significance: Elevated HOMA-IR indicates pancreatic beta cells are working excessively hard to maintain normal blood glucose levels, suggesting metabolic compensation for insulin resistance. This eventually leads to beta cell exhaustion and type 2 diabetes development. HOMA-IR is also associated with chronic inflammation, dyslipidemia, hypertension, and increased cardiovascular and all-cause mortality risk.
Associated Organs
- Primary Organ Systems: Pancreas (beta cells that produce insulin); Liver (glucose production and metabolism); Skeletal and cardiac muscle (glucose uptake sites); Adipose tissue (insulin sensitivity and inflammation); Endothelial cells (vascular function); Kidney (glucose reabsorption and metabolic clearance)
- Associated Medical Conditions: Type 2 diabetes mellitus; Prediabetes; Metabolic syndrome; Polycystic ovary syndrome (PCOS); Obesity and metabolic dysfunction-associated fatty liver disease (MAFLD); Cardiovascular disease and coronary artery disease; Hypertension; Dyslipidemia; Non-alcoholic fatty liver disease (NAFLD); Chronic kidney disease; Sleep apnea; Metabolic endotoxemia
- Diseases This Test Helps Diagnose: Insulin resistance syndrome; Metabolic syndrome; Type 2 diabetes; Prediabetes; PCOS with insulin resistance; Acanthosis nigricans (skin manifestation of insulin resistance); Hypertension related to insulin resistance
- Potential Complications of Abnormal Results: Progressive deterioration of glucose tolerance; Development of type 2 diabetes; Increased risk of myocardial infarction and stroke; Progression of atherosclerosis; Kidney disease progression; Retinopathy and vision loss; Neuropathy with pain and disability; Poor wound healing and increased infection risk; Cognitive decline and dementia; Increased mortality from all causes
Follow-up Tests
- Recommended Follow-up Tests: Fasting blood glucose; HbA1c (glycated hemoglobin); Oral glucose tolerance test (OGTT); Fasting insulin level; Fasting C-peptide level; Lipid panel (total cholesterol, LDL, HDL, triglycerides); Blood pressure; Body weight and BMI; Waist circumference
- Further Investigations: Liver function tests; Urinalysis and urine albumin-to-creatinine ratio; Kidney function tests (creatinine, eGFR); Uric acid level; High-sensitivity C-reactive protein (hs-CRP); Comprehensive metabolic panel; Thyroid function tests; Testosterone levels (in women with PCOS); Pelvic ultrasound (in women with PCOS)
- Monitoring Frequency: For borderline results (HOMA-IR 2.0-2.5): Repeat testing every 6-12 months; for elevated results (HOMA-IR > 2.5): Repeat testing every 3-6 months; for severely elevated results (HOMA-IR > 5.0): Retest every 1-3 months; HbA1c screening every 3-6 months if prediabetic; annual comprehensive metabolic assessment for all patients with elevated HOMA-IR
- Complementary Tests Providing Additional Information: Quantitative Insulin Sensitivity Check Index (QUICKI); Matsuda Index; Disposition Index; Beta cell function assessment; Advanced lipid panels; Apolipoprotein B; Lipoprotein(a); Homocysteine; Fibrinogen; Adiponectin levels; Leptin resistance markers; Inflammatory markers (IL-6, TNF-alpha); Endothelial dysfunction markers; Continuous glucose monitoring (CGM) in select cases
Fasting Required?
- Fasting Requirement: YES - Fasting is REQUIRED for accurate HOMA-IR results
- Fasting Duration: Minimum 8-10 hours of fasting required; overnight fasting (10-12 hours) is standard and preferred; blood draw typically performed between 6:00-10:00 AM after fasting overnight
- Special Instructions: Nothing to eat or drink except water after midnight (or 8-10 hours before test); no gum, candy, or mints; no smoking for at least 30 minutes before blood draw; avoid strenuous exercise for 12-24 hours before test; maintain normal sleep schedule night before test; arrive well-hydrated but avoid excessive water intake immediately before draw
- Medications to Avoid: Do NOT discontinue any prescribed medications without consulting healthcare provider; however, metformin may be held morning of test if directed; certain medications affecting glucose (corticosteroids, diuretics, antipsychotics) should be noted and documented; timing of medications should be discussed with healthcare provider prior to test; if possible, schedule test before morning medications, but do not alter medication regimen without medical advice
- Additional Patient Preparation: Sit quietly for 5-10 minutes before blood draw for accurate results; inform phlebotomist of medications and supplements you are taking; inform of any recent illness, stress, or unusual lifestyle changes; women should ideally have test performed in follicular phase of menstrual cycle (days 3-10) for consistency; keep records of previous HOMA-IR results for comparison; follow normal routine diet for 3 days before test (do not start new diet); inform provider if unable to fast or if any adverse health changes occurred since last test

How our test process works!